Compile Data Set for Download or QSAR
Report error Found 7 Enz. Inhib. hit(s) with all data for entry = 1194
TargetSodium-dependent dopamine transporter(Human)
Caliper Life Sciences

US Patent
LigandPNGBDBM312193(US9604945, 3 | 3-(p-methyl-benzyl)- syndonimine-N-...)
Affinity DataKi:  190nMAssay Description:1. Each tube receives the following components: 25 ul drug or vehicle 25 ul [3H]-Nisoxetine 200 ul tissue suspension. 2. Initiate binding reaction wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2019
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Human)
Caliper Life Sciences

US Patent
LigandPNGBDBM312223(US9604945, 7 | 3-(p-fluorobenzyl)- syndonimine-N- ...)
Affinity DataKi:  460nMAssay Description:1. Each tube receives the following components: 25 ul drug or vehicle 25 ul [3H]-Nisoxetine 200 ul tissue suspension. 2. Initiate binding reaction wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2019
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Human)
Caliper Life Sciences

US Patent
LigandPNGBDBM312192(US9604945, 2 | 3-(p-carboxylbenzyl)- syndonimine N...)
Affinity DataKi:  2.70E+3nMAssay Description:1. Each tube receives the following components: 25 ul drug or vehicle 25 ul [3H]-Nisoxetine 200 ul tissue suspension. 2. Initiate binding reaction wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2019
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Human)
Caliper Life Sciences

US Patent
LigandPNGBDBM312200(US9604945, 6 | 3-(phenylpropyl)- syndonimine-N- ph...)
Affinity DataKi:  2.50E+4nMAssay Description:1. Each tube receives the following components: 25 ul drug or vehicle 25 ul [3H]-Nisoxetine 200 ul tissue suspension. 2. Initiate binding reaction wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2019
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Human)
Caliper Life Sciences

US Patent
LigandPNGBDBM312189(US9604945, 1 | 3-(benzyl)- syndonimine-N- phenylca...)
Affinity DataKi:  3.60E+4nMAssay Description:1. Each tube receives the following components: 25 ul drug or vehicle 25 ul [3H]-Nisoxetine 200 ul tissue suspension. 2. Initiate binding reaction wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2019
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Human)
Caliper Life Sciences

US Patent
LigandPNGBDBM312195(US9604945, 4 | 3-phenethyl- syndonimine-N- (3',4'-...)
Affinity DataKi:  4.00E+4nMAssay Description:1. Each tube receives the following components: 25 ul drug or vehicle 25 ul [3H]-Nisoxetine 200 ul tissue suspension. 2. Initiate binding reaction wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2019
Entry Details
Go to US Patent

TargetSodium-dependent dopamine transporter(Human)
Caliper Life Sciences

US Patent
LigandPNGBDBM312196(US9604945, 5 | 3-(p-nitrophenethyl) syndonimine-N-...)
Affinity DataKi:  1.00E+5nMAssay Description:1. Each tube receives the following components: 25 ul drug or vehicle 25 ul [3H]-Nisoxetine 200 ul tissue suspension. 2. Initiate binding reaction wi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/23/2019
Entry Details
Go to US Patent